Rhenium-188
Re-188 · Rhenium, Z = 75, A = 188
Rhenium-188 (Re-188) carries 3.63e+16 Bq/g, or 9.80e+5 Ci/g: a gigabecquerel is 27.6 ng, no weighable quantity at all. It decays by beta-minus emission with a half-life of 17.005 hours, which leaves 37.60% of today's activity after a day and 0.11% after a week.
At 0.00753 mGy·m²/(GBq·h) the air kerma rate constant is 10× less than Cs-137 and 41× less than Co-60, placing it 75 of 96 photon emitters in this dataset.
Halving the air kerma rate calls for 1.49 mm of lead, or 7.63 mm of steel where lead is unwelcome, and a factor of ten calls for 16.9 mm of lead — sheet thicknesses that a glovebox or a transport container can carry. At 1 GBq and a metre the photon dose rate is already under 20 µSv/h with nothing in the way. The tenth-value layer runs 11.3 times the half-value layer, not the 3.32 a single energy would give.
The beta endpoint is 2.12 MeV, mean 0.763 MeV over 23 branches. That endpoint stops in 8.49 mm of acrylic or 4.04 mm of glass. Of the beta energy, 0.48% turns into X-rays in acrylic and 6.09% in lead.
Re-188 as a generator-produced therapy nuclide
Re-188 is a beta-emitting therapy nuclide usually eluted from a generator that holds its longer-lived parent, W-188, on an alumina column. It is used as labelled lipiodol for liver tumours, labelled phosphonates for bone pain and labelled microspheres, and historically in liquid-filled balloons for preventing restenosis after angioplasty; a paste for non-melanoma skin cancers is a newer use. Its chemistry resembles that of technetium, so many technetium labelling kits can be adapted, but perrhenate is much harder to reduce than pertechnetate, and the bone agent localises well only with stable rhenium carrier added.
The generator makes the nuclide available in places without reactor supply, though the parent needs a high-flux reactor: W-188 is made by double neutron capture in tungsten enriched in W-186, and its low activity per gram of tungsten makes the column large and the saline eluate dilute. To concentrate the eluate, a silver-based cartridge removes the chloride and a small anion exchanger retains the perrhenate for elution in a small volume.
Imaging of the distribution in the patient relies on one modest photon line, and a millimetre or two of lead removes most of it; the weaker, harder lines that pass thicker lead explain why the tenth-value layer spans so many half-value layers. The energetic therapeutic beta reaches up to about a centimetre into soft tissue, as the range figures here imply, and shielding during preparation is mainly a beta and bremsstrahlung matter.
When NIST standardised Re-188 by liquid scintillation counting, readings at the calibrator setting then recommended proved well above the true activity, and the corrected setting differed between a reference ampoule and a clinical dose vial, so each container type needs its own check. Tungsten breakthrough, normally very low, shows as activity persisting in a retained eluate sample, since the parent decays over months; traces of Os-191 and Ir-192 made alongside the parent can linger as well.
Since the half-life is hours, activity is used the day it is eluted and stored waste is down to a small fraction within about a week; the generator lasts for months. Unbound perrhenate leaves the body mainly in the urine, and the thyroid takes it up much as it does pertechnetate. A spent column still holds most of its enriched tungsten, recoverable for new targets but carrying longer-lived activity that would probably need special handling.
- LNHB / DDEP, Recommended nuclear data tables: Re-188
- Lepareur N et al., Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives, Frontiers in Medicine (2019)
- IAEA Radioisotopes and Radiopharmaceuticals Series No. 2, Production of Long Lived Parent Radionuclides for Generators: 68Ge, 82Sr, 90Sr and 188W
- Zimmerman BE et al., A new experimental determination of the dose calibrator setting for 188Re, Journal of Nuclear Medicine (1999)
Half-life, specific activity, dose rate and beta energies
| Half-life | 17.005 hours (6.122e+4 s) |
| Decay mode | beta-minus decay |
| Specific activity | 3.63e+16 Bq/g (9.80e+5 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.00753 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.00753 mGy/h |
| Dose rate, 1 Ci at 1 m | 0.278 mGy/h |
| Kerma-weighted mean photon energy | 545.2 keV |
| Beta endpoint / mean | 2.12 MeV / 0.763 MeV |
50 lines above the cutoff, and what each contributes
One further line below the 20 keV cutoff, at 10.39 keV with 3.04% emission probability, is excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 155.04 | 15.49 | 36.84 |
| 633.03 | 1.37 | 15.55 |
| 931.34 | 0.595 | 9.52 |
| 478.00 | 1.076 | 9.29 |
| 829.47 | 0.444 | 6.44 |
| 63.00 | 2.41348 | 2.71 |
| 1610.40 | 0.1037 | 2.54 |
| 634.97 | 0.1604 | 1.83 |
| 1132.31 | 0.0908 | 1.71 |
| 61.49 | 1.40054 | 1.57 |
| 1308.03 | 0.0705 | 1.48 |
| 672.54 | 0.1198 | 1.44 |
| 1802.05 | 0.0392 | 1.04 |
| 71.50 | 0.8075 | 0.93 |
Showing the 14 largest contributors of 50 lines above the cutoff; the remainder together carry 7.12% of the dose rate.
1.49 mm of lead halves this spectrum
Solved numerically across all 50 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 1.49 | 16.9 | 11.31 |
| tungsten | 1.03 | 10.9 | 10.53 |
| iron | 7.63 | 33.7 | 4.42 |
| copper | 6.40 | 29.8 | 4.66 |
| concrete | 29.7 | 112 | 3.79 |
| water | 64.7 | 239 | 3.70 |
| aluminum | 26.4 | 101 | 3.81 |
A single energy would give 3.32. Spectrum and attenuation ratios.
8.49 mm of acrylic stops the 2.12 MeV endpoint
Katz–Penfold fit to the 2.12 MeV endpoint — a stopping thickness rather than an attenuation length. Why the material matters more than the thickness.
| Absorber | Range for the endpoint (mm) |
|---|---|
| acrylic | 8.49 |
| aluminum | 3.74 |
| water | 10.1 |
| glass | 4.04 |
| Shield material | Fraction of beta energy converted to X-rays |
|---|---|
| acrylic (Z ≈ 6.5) | 0.48% |
| lead (Z = 82) | 6.09% |
Activity over days and weeks
Ten half-lives is 7.09 days, so the activity moves measurably while a count is running: every figure has to carry the time it was referred to. The mean life 1/λ is 1.02 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 2.35 days |
| Time to fall to 1 % | 4.71 days |
| Time to fall to 0.1 % | 7.06 days |
Limits of these dose rates
- 8.49 mm of acrylic for the 2.12 MeV endpoint: a fitted depth of penetration, not a skin dose.
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma, beta and decay calculators for Re-188
- Gamma dose rate and shielding
- Beta dose rate and shielding
- Decay and half-life
- Mass and activity
- Detection limits (MDA / MDC)
Other Rhenium nuclides: Re-188m
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.